APOA1 and Alzheimer disease: Another area of contention lies in ApoA-I levels in AD: while reduced serum ApoA-I is often associated with increased AD risk, CSF ApoA-I levels show variable trends, with some studies suggesting a protective role and others indicating a maladaptive response in advanced disease stages [122,123,139,140].